All About The Latest Anti-Amyloid Alzheimer’s Drug
ALL ABOUT THE LATEST ANTI-AMYLOID ALZHEIMER’S DRUG On July 2, the FDA approved a new Alzheimer’s drug called donanemab, which will be marketed under the brand name Kisunla. Developed by Eli Lilly, this drug is an antibody designed to remove beta-amyloid plaques that accumulate in the brains of Alzheimer’s patients. It is similar to another drug, lecanemab (brand name Leqembi), made by Eisai and Biogen. (Refer to my August 2023 post Lecanemab: the new Alzheimer’s Drug.) This marks the third amyloid-clearing Alzheimer’s drug approved in the last three years. In 2021, the FDA approved Biogen’s aducanumab (sold as Aduhelm), despite...